“We believe this study will contribute to a growing body of literature demonstrating the national lack of adherence to the NCCN guidelines," says Dr. Matthews.
Greensboro, GA (PRWEB) September 12, 2012
A recent study conducted by researchers at Stanford University supports what many oncologists have presumed for some time – the failure to comply with the National Comprehensive Cancer Network (“NCCN®”) Guidelines for cancer management could compromise a patient’s outcome (1). The study confirmed this in pancreatic cancer patients and went one step further, linking physician compliance with the NCCN® guidelines with improved survival in this patient group.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN® Member Institutions, NCCN® develops resources that present valuable information to the numerous stakeholders in the health care delivery system.
Using the California Cancer Registry, the study identified 3,706 patients who were treated for pancreatic cancer in large hospitals between 2001 to 2006. Only 34.5% of patient care was compliant with the NCCN® guidelines. It found that those patients who had high rates of compliance with NCCN® pancreatic cancer guidelines had improved rates of survival. In contrast, those patients who largely failed to adhere to the guidelines generally had more negative outcomes. As a result, the study concluded that being compliant with NCCN® guidelines is an important potential measure of the quality of an individual’s care.
OncCharts.com is the only online service that allows a cancer patient and their oncologist to track their treatment course step-for-step with the NCCN® guidelines for patients. Dr. Charles Matthews, founder of OncCharts.com states, "This new study provides three very important take home points for all cancer patients: (1) cancer patients should not assume their cancer care is properly following the NCCN® guidelines; (2) it is evidence that the NCCN® guidelines are an essential resource to oncologists and patients in the proper treatment of cancer in the United States; and (3) the OncCharts.com service may not only be important, but potentially critical to optimizing one's cancer outcome.”
“We believe this study will contribute to a growing body of literature demonstrating the national lack of adherence to the NCCN® guidelines, and the need for patients to actively invest in their own well-being by tracking their care through services such as OncCharts,” says Dr. Matthews.
Created by oncologists, OncCharts is a simple online tool that protects patients by enabling them to follow their cancer care as it happens with the NCCN® guidelines for patients. OncCharts services prostate, lung, breast, and colon cancer patients. OncCharts has been profiled in the San Francisco Chronicle, Houston Chronicle, Yahoo News, among other media outlets. The service can be sent as a gift to loved ones with cancer, which can be found here. For more information or view the video on how the OncCharts.com platform works, please visit OncCharts.com. Visit Onccharts.com on Facebook or join the conversation on Twitter.
1. HPB (Oxford). 2012 Aug;14(8):539-47. doi: 10.1111/j.1477-2574.2012.00496.x. Epub 2012 Jun 12.